Biogen Inc. stock outperforms competitors on strong trading day
Published: March 1, 2024 at 5:04 p.m. ET
Shares of Biogen Inc. BIIB advanced 1.82% to $220.95 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.80% to 5,137.08 and the Dow Jones Industrial Average DJIA rising 0.23% to 39,087.38.
The stock’s rise snapped a two-day losing streak.
Biogen Inc. closed $98.81…
Shares of Biogen Inc.
BIIB
advanced 1.82% to $220.95 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
SPX
rising 0.80% to 5,137.08 and the Dow Jones Industrial Average
DJIA
rising 0.23% to 39,087.38.
The stock’s rise snapped a two-day losing streak.
Biogen Inc. closed $98.81 short of its 52-week high ($319.76), which the company reached on June 12th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson
JNJ
rose 0.46% to $162.12 and Pfizer Inc.
PFE
rose 0.11% to $26.59.
Trading volume (1.1 M) eclipsed its 50-day average volume of 1.1 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
